TILT Launches CCELL's New EVO Via Jupiter Research And Amends Facility Purchase And Sale Agreement With IIPR

CCELL by Smoore’s latest technology release, EVO, is now available through Jupiter Research, LLC, a wholly-owned subsidiary of TILT Holdings Inc. TLLTF TILT

EVO features an entirely new atomizer for better thermal output, leading to consistent performance and a stronger user experience. The atomizer includes refined ceramics with even pore sizing that supports even distribution of product across the heating element, which is also modified to be larger and thinner. EVO’s consistent pore sizes and large heating surface have proven in side-by-side comparison studies to improve the detection of terpenes, increase vapor clouds and maintain quality consistency from first use to last. CCELL EVO is compatible for use with traditional distillates, as well as high terpene extracts.

In addition to cartridge enhancements, CCELL also reformed its production process to reduce environmental impacts. The new manufacturing process allows for multiple uses of raw materials, cutting down on waste. Plus, EVO is cast in an aqueous system that requires less power due to increased efficiencies.

Amendment of Facility Purchase and Sale Agreement

TILT has signed a fourth amendment to its definitive agreement with Innovative Industrial Properties, Inc. IIPR to sell and leaseback its White Haven, Pennsylvania facility. The amendment allows TILT and IIPR to extend the end of the investigational period of the transaction contemplated to a date that is on or before December 31, 2022.

Extension of Maturity Date for Certain Senior Debt Holders

The company has entered into amendments to the senior secured promissory notes held by certain senior debt noteholders totaling $9.6 million to extend the maturity date from November 1, 2022, to November 14, 2022, in exchange for an increase in the interest rate to prime plus 8.5%.

Photo: Courtesy of CCELL

Related News